Description

Hamps Bio Limited provides revised undertaking for crediting bonus shares to beneficiaries by September 10, 2025, with trading to commence September 11, 2025.

Summary

Hamps Bio Limited (Scrip Code: 544312, ISIN: INEOQBD01018) has submitted a revised undertaking to BSE regarding the crediting of bonus shares to beneficiaries’ accounts. The company commits to credit up to 43,56,000 bonus shares by 12:00 PM on September 10, 2025, with trading to commence on September 11, 2025.

Key Points

  • Revised record date: September 09, 2025
  • Share crediting deadline: September 10, 2025 by 12:00 PM (T+1)
  • Trading commencement: September 11, 2025 at beginning of day (T+2)
  • Maximum bonus shares: 43,56,000
  • Distinctive numbers: 43,56,001 to 87,12,000
  • Deemed allotment date: September 10, 2025

Regulatory Changes

No regulatory changes introduced. This circular represents compliance with existing SEBI Circular No. SEBI/CFD/PoD/2024/122 dated September 16, 2024, regarding bonus share crediting timelines.

Compliance Requirements

  • Company must credit bonus shares to depository accounts by 12:00 PM on T+1 day
  • Shares must be available for trading at BOD on T+2 day
  • Undertaking submitted as per BSE requirements and SEBI guidelines
  • Company must maintain distinctive number allocation as specified

Important Dates

  • Record Date: September 09, 2025
  • Share Crediting Deadline: September 10, 2025 (12:00 PM)
  • Trading Commencement: September 11, 2025 (BOD)
  • Deemed Allotment Date: September 10, 2025

Impact Assessment

Medium impact on Hamps Bio Limited shareholders who will receive bonus shares in 1:1 ratio based on the share count. The defined timeline ensures orderly processing of corporate action with minimal market disruption. Trading resumption on T+2 follows standard market practices for bonus issues.

Impact Justification

Standard corporate action affecting single stock with defined timeline and regulatory compliance requirements